BullFrog AI (BFRGW) Stock: Why It's Down Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $0.09, -33.46% vs the prior close of $0.13.
- Volume 7.21K shares, 7.7x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BFRGW slides 33.5% to $0.09 on 7.7x normal volume. Closed at $0.09, -33.46% vs the prior close of $0.13. Day range $0.08–$0.12, opened at $0.44.
BFRGW daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — BFRGW slides 33.5% to $0.09 on 7.7x normal volume
- Closed at $0.09, -33.46% vs the prior close of $0.13. Day range $0.08–$0.12, opened at $0.44.
- Volume was 7.21K shares, 7.7x its 50-day average of 938 — unusually heavy trading.
- 52-week range $0.08–$0.16; today's close sits at 4% of that range, 45.9% below the 52-week high.
BFRGW bull case vs bear case (from the data)
- Annual revenue grew 79.5% in the latest fiscal year (SEC XBRL).
- Insiders made 8 open-market purchases in the last 12 months.
- Latest fiscal-year net income: loss of $6.50M.
- Share count up 83.9% in a year (dilution).
- High volatility: average daily move of 33.5% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
BFRGW latest news & SEC filings
Every SEC filing by or about BFRGW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Blacher Joshua bought 50,000 shares at $0.53 (≈$26.43K) on Sep 22, 2026; now holds 65,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Singh Vininder bought 75,000 shares at $0.60 (≈$44.92K) on Sep 22, 2026; now holds 2,442,446
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $215.38K (prior year $33.26K) (+547.6% vs Jun 30, 2025)
- Net income: -$1.37M (prior year -$1.45M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.07 (prior year -$0.15) (loss narrowed vs Jun 30, 2025)
Jul 6, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade BFRGW
- How much it moves: over the last 20 sessions the average daily move was 33.46% (largest 33.5%). That is a volatile stock.
- Liquidity: about 4.08K shares (≈$352) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.09 vs a range of $0.08–$0.16 (4% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 0 sales; latest: Vininder Singh bought 75,000 shares on Sep 22, 2026.
- Latest filings: 8-K Aug 20, 2026; 10-Q Aug 14, 2026; 8-K Jun 15, 2026.
- Share count: 18.54M shares outstanding (Aug 13, 2026), +83.9% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
BFRGW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.44 | 0.12 | 0.08 | 0.09 | 7.21K |
| Oct 14, 2026 | 0.44 | 0.16 | 0.09 | 0.13 | 938 |
About BullFrog AI
BullFrog AI (BFRGW) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in GAITHERSBURG, MD. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1829247.
BFRGW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| R Don Elsey | Director | Jun 15, 2026 |
| William Enright | Director | Jun 15, 2026 |
| Jason David Hanson | Director | Jun 15, 2026 |
| Vininder Singh | Chief Executive Officer | Sep 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Joshua Blacher | Chief Financial Officer | Sep 22, 2026 |
| Vininder Singh | Chief Executive Officer | Sep 22, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 22, 2026 | Vininder Singh | Buy | 75,000 | $0.60 |
| Sep 22, 2026 | Vininder Singh | Buy | 75,000 | $0.60 |
| Sep 22, 2026 | Vininder Singh | Buy | 75,000 | $0.60 |
| Sep 22, 2026 | Vininder Singh | Buy | 75,000 | $0.60 |
| Sep 22, 2026 | Joshua Blacher | Buy | 50,000 | $0.53 |
| Sep 22, 2026 | Joshua Blacher | Buy | 50,000 | $0.53 |
| Sep 22, 2026 | Joshua Blacher | Buy | 50,000 | $0.53 |
| Sep 22, 2026 | Joshua Blacher | Buy | 50,000 | $0.53 |
BFRGW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $116.67K | $-6.50M | -0.63 | $-5.52M |
| Dec 31, 2024 | — | $-6.99M | -0.85 | $-5.61M |
| Dec 31, 2023 | $65.00K | $-5.36M | -0.89 | $-6.00M |
| Dec 31, 2022 | $10.00K | $-2.80M | -0.70 | $-910.89K |
| Dec 31, 2021 | — | $-585.84K | — | $-382.40K |
Latest balance sheet: total assets $7.69M, total liabilities $706.59K, cash $6.92M (as of Jun 30, 2026).
BFRGW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on BFRGW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.